Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.85 -0.37 (-2.03%)
As of: Oct 2, 2026 · 1:19 PM EDT

Syndax Pharmaceuticals (SNDX) Invested Capital (2020 - 2026)

Updated

Syndax Pharmaceuticals' Invested Capital came in at $359.13 million for Q2 2026, down 25.5% from $481.84 million a year earlier and down 6.9% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Invested Capital (2020 - 2026) Analysis & Trends

For FY2025, Syndax Pharmaceuticals' Invested Capital was $408.54 million, down 35.3% from FY2024.

  • Invested Capital carries a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
  • Going back by year, Invested Capital was $631.81 million in FY2024 (+14.0%), $554.2 million in FY2023 (+18.6%), $467.45 million in FY2022 (+9.1%) and $428.26 million in FY2021 (+57.3%).
  • The Q2 2026 figure represents the lowest quarterly Invested Capital since Q3 2022.
  • Year-over-year, Invested Capital has declined for three consecutive quarters, with an average decline of 19.0% over the last four quarters.
  • The fastest year-over-year change in Invested Capital over five years came in Q2 2022 (growth of 62.7%), and the weakest in Q4 2025 (a decline of 35.3%).
  • Business Quant data shows SNDX's Invested Capital at $385.59 million (Q1 2026), $408.54 million (Q4 2025) and $436.42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn 359.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 359.13 Mn
Mar 31, 2026 385.59 Mn
Dec 31, 2025 408.54 Mn
Sep 30, 2025 436.42 Mn
Jun 30, 2025 481.84 Mn
Mar 31, 2025 544.70 Mn
Dec 31, 2024 631.81 Mn
Dec 31, 2023 554.20 Mn
Dec 31, 2022 467.45 Mn
Sep 30, 2022 338.10 Mn
Jun 30, 2022 382.15 Mn
Mar 31, 2022 394.60 Mn
Dec 31, 2021 428.26 Mn
Sep 30, 2021 219.48 Mn
Jun 30, 2021 234.92 Mn
Mar 31, 2021 248.44 Mn
Dec 31, 2020 272.31 Mn
Sep 30, 2020 151.98 Mn
Jun 30, 2020 167.54 Mn
Mar 31, 2020 73.30 Mn
API Access

Syndax Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=SNDX&period=max&api_key=YOUR_API_KEY